Life Sciences 25

Boston Scientific reported that its top executive received more than $23 million in compensation last year; Biogen Idec was upgraded by BWS Financial.

	LAST			MARKET CAP	LAST	PCT.
NO.	WEEK	COMPANY	TICKER	(MILLIONS)	PRICE	CHANGE
1	1	Boston Scientific Corp.	BSX	$23,345	$15.77	-1.4%
2	2	Thermo Fisher Scientific	TMO	$19,292	$45.93	3.8%
3	3	Genzyme Corp.	GENZ	$15,847	$60.15	-1.3%
4	4	Biogen Idec	BIIB	$14,828	$43.30	-0.8%
5	5	Waters Corp.	WAT	$5,533	$54.50	-0.9%
6	6	Sepracor	SEPR	$5,512	$50.03	1.2%
7	7	Millipore Corp.	MIL	$3,905	$72.40	1.8%
8	9	Cytyc Corp.	CYTC	$3,736	$32.55	7.9%
9	8	Vertex Pharmaceuticals	VRTX	$3,710	$29.29	-0.6%
10	10	Millennium Pharmaceuticals	MLNM	$3,381	$10.64	2.8%
11	11	Charles River Laboratories	CRL	$2,986	$44.61	-1.2%
12	12	Hologic	HOLX	$2,931	$55.05	2.6%
13	13	PerkinElmer	PKI	$2,833	$23.25	0.0%
14	14	Alkermes	ALKS	$1,583	$15.68	2.0%
15	15	Haemonetics Corp.	HAE	$1,184	$44.80	1.5%
16	16	Cubist Pharmaceuticals	CBST	$1,067	$19.47	0.4%
17	17	Bruker BioSciences Corp.	BRKR	$1,024	$9.77	5.5%
18	18	PolyMedica Corp.	PLMD	$905	$40.04	-1.1%
19	19	Advanced Magnetics	AMAG	$826	$58.40	5.1%
20	20	Palomar Medical Technologies	PMTI	$673	$38.08	-2.4%
21	21	Alnylam Pharmaceuticals	ALNY	$656	$17.73	0.4%
22	22	Zoll Medical Corp.	ZOLL	$550	$27.46	2.1%
23	24	Phase Forward	PFWD	$494	$14.00	6.4%
24	23	Idenix Pharmaceuticals	IDIX	$463	$8.26	-1.3%
25	25	Momenta Pharmaceuticals	MNTA	$446	$12.37	8.3%

The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business.